Partner Forum

4 Ways To Market CAR-T Therapies

4 Ways To Market CAR-T Therapies

How should marketers position this new type of cancer therapy?

4 Ways to Create Adherence Programs That Lead to Long-Term Change

4 Ways to Create Adherence Programs That Lead to Long-Term Change

How can marketers do more with less, or otherwise convince skeptical executives that more resources will lead to long-term change?

4 Ways to Execute a Point-of-Care Strategy That Works for Patients

4 Ways to Execute a Point-of-Care Strategy That Works for Patients

How can marketers ensure that patients and physicians aren't overwhelmed by these tactics?

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

As the influence of patient communities and advocacy groups grows, how can marketers work these organizations to achieve brand objectives?

4 Ways to Help Pharma Understand and Better Use Big Data

4 Ways to Help Pharma Understand and Better Use Big Data

As drugmakers hire economists and pharmacologists to better grapple with big data, how can ad agencies ensure they're not left behind?

4 Ways to Communicate the Value of Specialty Drugs

4 Ways to Communicate the Value of Specialty Drugs

Beset by high prices and scientific complexity, how can marketers best communicate the value of specialty drugs?

4 Ways for Agencies to Sell Clients on Behavioral Marketing Programs

4 Ways for Agencies to Sell Clients on Behavioral Marketing Programs

How can agencies best entice clients to incorporate behavioral science into their marketing programs?

4 Ways Marketers Can Create Valuable Content That Achieves Brand Objectives

4 Ways Marketers Can Create Valuable Content That Achieves Brand Objectives

"Find exactly what your audience wants, find exactly where they spend their time, and deliver."

4 Ways to Create a Dialogue With Patients Without Costly Studies

4 Ways to Create a Dialogue With Patients Without Costly Studies

How can marketers incorporate patient feedback into their marketing strategies without expensive and time-consuming studies?

4 Ways Drugmakers Can Best Reach 'No-See' Docs

4 Ways Drugmakers Can Best Reach 'No-See' Docs

With rep access to physicians on the decline, what are the most effective non-personal promotional tactics marketers can use to connect with prescribers?

4 Ways Dwindling Pharma Sales Detailing Will Affect the Cloud

4 Ways Dwindling Pharma Sales Detailing Will Affect the Cloud

As the effectiveness of in-person detailing wanes, how will cloud-based content solutions adapt?

4 Ways for Marketers To Differentiate Their Brands In The Rare-Disease Space

4 Ways for Marketers To Differentiate Their Brands In The Rare-Disease Space

Data analytics, relationship building, and improved patient support are the keys to differentiating your rare-disease drug brands, according to these four marketers.

How Can Marketers Best Unleash the Potential of Virtual Reality?

How Can Marketers Best Unleash the Potential of Virtual Reality?

Does virtual reality represent a new way for marketers to create immersive experiences — or is this just the industry's latest shiny object?

How Should Pharma Deploy Messaging in EHR Systems?

How Should Pharma Deploy Messaging in EHR Systems?

Pharma must be thoughtful in its approach and demonstrate value to be part of the EHR conversation.

Do We Need Formal Surveys Anymore?

Do We Need Formal Surveys Anymore?

"Social can enable a better starting point to yield better questions and thus make surveys less in number yet greater in value."

Will Network Agencies Retain their Brand's Identities if They Collaborate with Sister Firms?

Will Network Agencies Retain their Brand's Identities if They Collaborate with Sister Firms?

"Under pressure to perform, even team players will covet their neighbors' budgets and begin to compete. And there goes homogeneity."

4 Ways to Help Audiences Propel Branded Content

4 Ways to Help Audiences Propel Branded Content

How can marketers give their audience the ability to propel a healthcare brand's story?

4 Industry Execs Examine the State of Physician-Rep Access

4 Industry Execs Examine the State of Physician-Rep Access

Recent polls paint a mixed picture of physicians' willingness to see pharma sales reps. What gives? Are no-see docs up or down, and what's behind the dissonant findings?

4 Ways to Create a Sustainable Pricing Model

4 Ways to Create a Sustainable Pricing Model

The formula's pretty simple: Be sure you can defend your drug's value proposition, without blushing, says BioPharma Alliance's Mike Luby.

What Is The Real Value of Market Research?

What Is The Real Value of Market Research?

By

Layoffs at CPG companies have begun, including significant numbers in the research function at major corporations. Is healthcare market research insulated from this trend?

Why the Holdup in Patient Portals?

Patient portals are clearly underutilized as a patient resource. Although their use is increasing among a population hungry for health information, what can industry do to foster and promote their use?

Partner Forum: Will Predictive Analytics Sell?

By

Can predictive analytics, embedded into CRM, fulfill the promise on which closed-loop marketing fell short: Allow pharma to harness data from rep visits to make their upcoming digital sales pitches smarter?

Partner Forum: Are Wearables a Pharma Field Day?

By

The arrival of the Apple Watch—following hardware from Samsung and others—has sparked interest among app developers for use in consumer healthcare. Do wearables have a role in life-science sales and CRM?

Partner Forum: Pharma—Powered by Service?

By

Healthcare professionals' customer experiences are increasingly being shaped by retailers like Amazon and Zappos. What ideas should drugmakers borrow from them to personalize promotion and what are the limits?

Partner Forum: Social for HCPs—Is Now the Time?

The increasing use of social media to reach consumers in the healthcare arena raises questions: Is it time to leverage it for HCPs, and if so, what are the most viable platforms for pharma-HCP communications?

Partner Forum: MLR is Important. What Drives it?

Sorting out competing priorities is one way to expedite medical-legal review. What should drive work flow—great creative for the brand or need to mitigate risk (compliance, legal, medical, regulatory, brand image)?

Partner Forum: Can Evidence Show POC the Way?

EHRs can deliver evidence-based information about giving the right medicine to the right patient at the right time. How can industry craft point-of-care marketing that is both relevant and useful?

Does Account + Creative ≠ Agency?

Changing pharma demands and the ever-expanding skills of job seekers (tech, UX, search, mobile) have altered agency team structure. How must agency-client relations change to keep to the new model?

Is Pharma Equipped to Prove Value?

Delivering better patient outcomes takes the right economic instruments. Do market-access teams have the right tools at their disposal to make the value-for-money argument?

Partner Forum: Is data the key to trial recruitment?

LabCorp's purchase of CRO Covance promises to open access to LabCorp's patient database for trial recruiting. Can this help resolve problems like the disparity of female representation and scarcity of subjects for studies?

Is guidance stifling social media?

By

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Has risk information run rampant?

By

In an era when many patients prefer a conversation over a commercial, and as the FDA considers revisions to the "brief summary," how much risk information is necessary in DTC ads and why?

Are discounts cutting out co-pays?

By

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?

Can value vanquish payer pressure?

By

Pharma cites "payer pressure" as one of its biggest marketing challenges yet struggles to make the "value" case for products. How can it translate market-access awareness into reimbursement success?

Can EHRs raise the quality of care?

By

Stage 1 of the three stages of meaningful use criteria has ended, and Stage 2 is rolling out. So far, it's unclear if the incentives improve patient care. How can industry help doctors bridge the quality gap through EHRs?

Can local and global live together?

By

As brand communications responsibilities shift from local markets to centralized hubs, what will happen to the smaller, local agencies, and what will regionalization mean in terms of preserving choice for Rx clients?

Are rep networks a solid resource?

By

Research shows HCPs bounce from site to site, so rep networks seem to offer both one-stop info shopping and industry contact. But do they provide quality interaction, or are they just a way to e-mail marketing materials?

How do we make the mobile move?

By

With physicians and patients engaging in more cross-platform behavior, marketers must be multi-screen to reach them. Yet only one-third of pharma sites are mobile-optimized. Can we catch up with our customers?

What's the RX for specialty meds?

By

Unmet need has turned pharma toward specialty meds. Yet every success reduces unmet need, raising the bar. In this landscape, how do you ensure that a small-audience drug has a compelling value proposition at launch?

Can analytics hit the ROI target?

By

How are analytics, targeting and other forces augmenting ROI measurement?

How will the cloud change pharma?

By

Cloud-based CRM, which has been adopted by many a biopharma, has capabilities beyond carrying rep data. What are you doing technologically to ensure clients' field reps and tele-detailers stay on the cutting edge?

What's the key to communicating?

What's the key to communicating?

By

Healthcare reform opens the door for innovative communications among patients, payers and physicians. But how can disparate data sets and stakeholders from across a conservative, silo-ridden industry work together?

What's the gamification game plan?

By

Patients and physicians each can benefit from gamification: Patients gain a sense of control and connection, physicians can boost competencies. How can games foster better communication between the two groups?

Can no-see restrictions be solved?

By

How can industry reach HCPs who don't see sales reps?

How can digital fill clinical trials?

By

What are some ways that pharma could use websites, analytics and social media to boost enrollment in clinical trials?

How can pharma build digital DNA?

By

Pharmas are restructuring to implement digital marketing initiatives—for instance, using social media to build brands or engage audiences. As they partner, how should agencies help them cultivate a digital DNA?

How can DTC break new ground?

By

What device and/or diagnostic marketing advances will emerge in DTC, and how should such companies experiment with media?

Balancing promotion and education

By

How can agencies establish brand identities for specialty drugs without looking too self-promotional?

Can Big Data justify big budgets?

By

Big Data holds promise for helping pharma boost efficiencies, but the business case for new analytic techniques, in many cases, is still being written. How do you justify budgeting for data-management technologies?

How can specialty dollars do more?

By

Specialty pharma budgets can be smaller than in primary care, yet the conversations with specialists and ­payers are often more complex. How do you maximize reach with a lower spend?